Benjamin T. Dake

466 total citations
7 papers, 355 citations indexed

About

Benjamin T. Dake is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin T. Dake has authored 7 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin T. Dake's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cancer Cells and Metastasis (2 papers). Benjamin T. Dake is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cancer Cells and Metastasis (2 papers). Benjamin T. Dake collaborates with scholars based in United States, Germany and France. Benjamin T. Dake's co-authors include Charlotte Kuperwasser, Sarah Naomi Olsen, Karen Cichowski, Thomas De Raedt, Henry Yim Wu, Howard L. Weiner, Andre Pires da Cunha, Francisco J. Quintana, Thomas Koeglsperger and Sarah C. Starossom and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Cell.

In The Last Decade

Benjamin T. Dake

7 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin T. Dake United States 6 218 71 69 53 48 7 355
Markus Linder Austria 7 190 0.9× 73 1.0× 76 1.1× 61 1.2× 44 0.9× 10 309
Marina Kolesnichenko Germany 12 212 1.0× 80 1.1× 83 1.2× 64 1.2× 25 0.5× 13 379
Hidetaka Ohnuki United States 10 204 0.9× 83 1.2× 75 1.1× 47 0.9× 33 0.7× 23 385
Terry J. Shackleford United States 6 220 1.0× 42 0.6× 114 1.7× 64 1.2× 48 1.0× 11 320
Ting‐Yu Lin Taiwan 10 178 0.8× 55 0.8× 69 1.0× 53 1.0× 37 0.8× 17 317
Dimitris C. Kanellis Denmark 10 209 1.0× 62 0.9× 85 1.2× 88 1.7× 31 0.6× 14 323
Zhaojie Lyu China 9 195 0.9× 71 1.0× 61 0.9× 88 1.7× 59 1.2× 21 362
Yimin Lao China 9 247 1.1× 85 1.2× 67 1.0× 63 1.2× 33 0.7× 11 324
Emilie Evanno France 6 208 1.0× 52 0.7× 62 0.9× 72 1.4× 28 0.6× 7 334

Countries citing papers authored by Benjamin T. Dake

Since Specialization
Citations

This map shows the geographic impact of Benjamin T. Dake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin T. Dake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin T. Dake more than expected).

Fields of papers citing papers by Benjamin T. Dake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin T. Dake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin T. Dake. The network helps show where Benjamin T. Dake may publish in the future.

Co-authorship network of co-authors of Benjamin T. Dake

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin T. Dake. A scholar is included among the top collaborators of Benjamin T. Dake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin T. Dake. Benjamin T. Dake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Gillies, Hunter, Murali M. Chakinala, Benjamin T. Dake, et al.. (2024). IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension. Pulmonary Circulation. 14(1). e12352–e12352. 5 indexed citations
2.
Gillies, Hunter, Ralph W. Niven, Benjamin T. Dake, et al.. (2022). AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study. ERJ Open Research. 9(2). 433–2022. 21 indexed citations
3.
Olsen, Sarah Naomi, Ania Wronski, Zafira Castaño, et al.. (2016). Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discovery. 7(2). 202–217. 52 indexed citations
4.
Kottakis, Filippos, Parthena Foltopoulou, Ioannis Sanidas, et al.. (2014). NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells. Cancer Research. 74(14). 3935–3946. 68 indexed citations
5.
McLaughlin, Sara Koenig, Sarah Naomi Olsen, Benjamin T. Dake, et al.. (2013). The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor. Cancer Cell. 24(3). 365–378. 102 indexed citations
6.
Zhu, Cong, Ankit Gupta, Victoria L. Hall, et al.. (2013). Using defined finger–finger interfaces as units of assembly for constructing zinc-finger nucleases. Nucleic Acids Research. 41(4). 2455–2465. 23 indexed citations
7.
Wu, Henry Yim, Francisco J. Quintana, Andre Pires da Cunha, et al.. (2011). In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling. PLoS ONE. 6(8). e23618–e23618. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026